The PROPEL Sinus Stent FDA Page
An encouraging development this week: the FDA approval page for the PROPEL sinus stent is finally up for public review.
If you’ve never heard of it, the PROPEL stent is a pleasingly simple invention: a soft, springy structure that holds the airway open following sinus surgery. The stent releases a steroid into the surrounding tissues to help promote healing and “firm up” the proper position. Here’s the FDA:
The Propel sinus implant is a temporary, self-absorbing implant designed to keep the spaces within and around the sinuses open following sinus surgery. The Propel sinus implant is manufactured from a synthetic material which is absorbed by the body over 4 to 6 weeks following implantation. The implant contains the active ingredient, mometasone furoate, a steroid which suppresses inflammation in the area around the implant.
I am proud to have been among the first sinus surgeons in the U.S. to offer this effective new device. Helping patients to breathe better, heal faster and enjoy their active lives is the greatest joy of my work as an ENT. If you’d like to learn more about PROPEL, sinus surgery or the latest medical innovations, please contact my LA sinus offices here today.